Zhihui Li, Qinlong Zheng, Keyan Yang, Xianxuan Wang, Jing Li, Qian Fei, Jiahong Zhai, Zongyang Ming, Xiaopei Wen, Yanzhi Song, Yongqiang Zhao, Lei Wang, Tong Wu. "Pre-transplant MRD negativity and TP53 mutation status determine survival after CAR-T therapy bridged to allo-HSCT for refractory/relapse B-ALL.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6556